Clinical trial
Early Changes in OCT Biomarkers After the First Intravitreal Anti-VEGF Injection in Treatment-naïve DME
NCT06841250 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Changes in OCT Biomarkers After the First Intravitreal Anti-VEGF Injection in Treatment-naïve DME
- Lead sponsor
- Sohag University
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 16, 2025
- Completion date
- January 16, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
early oct biomarker changes in response to anti-vegf